Cf. Berthelin et al., CRYPTOCOCCOSIS OF THE NERVOUS-SYSTEM IN DOGS, .2. DIAGNOSIS, TREATMENT, MONITORING, AND PROGNOSIS, Progress in veterinary neurology, 5(4), 1994, pp. 136-146
The diagnostic, therapeutic, and prognostic features of CNS cryptococc
osis in dogs are updated using data from 13 new cases and from previou
s literature. Cerebrospinal fluid (CSF) latex agglutination cryptococc
al antigen (CRAG) titers may be more sensitive for the diagnosis of CN
S cryptococcosis in dogs than CSF cytology, India ink preparation and
culture. Cerebrospinal fluid CRAG titers are preferred to serum CRAG t
iters which may not reflect the level of CNS infection. Based on limit
ed information in dogs and on promising results in other species, itra
conazole and fluconazole are recommended for the treatment of CNS cryp
tococcosis in dogs. Disease recurrence occurred in three dogs, up to 3
0 months after apparent recovery. In vitro sensitivity testing of cryp
tococcal isolates, and monitoring of patients with routine CSF analysi
s, CSF culture and CSF CRAG titer may optimize the chances of a cure.